<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR24">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chester</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Ambulkar</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Kohrt</surname>
    <given-names>HE</given-names>
   </name>
  </person-group>
  <article-title>4-1BB agonism: adding the accelerator to cancer immunotherapy</article-title>
  <source>Cancer Immunol. Immunother.</source>
  <year>2016</year>
  <volume>65</volume>
  <fpage>1243</fpage>
  <lpage>1248</lpage>
  <?supplied-pmid 27034234?>
  <pub-id pub-id-type="pmid">27034234</pub-id>
 </element-citation>
</ref>
